Class II
Terminated
BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0.2 %, 3.5 g tube, Rx only, ALLERGAN, Irvine, California 92612, NDC 0023-0313-04, UPC 3 00230 31304 9.
Why: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.
- Company
- Allergan Sales, LLC
Waco, TX, United States - Reported
- Sep 30, 2015
- Recall started
- Aug 24, 2015
- Ended
- Apr 19, 2017
- Where sold
- Nationwide, Puerto Rico, and Barbados
- Amount
- 337 tubes
- Full product description
- BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0.2 %, 3.5 g tube, Rx only, ALLERGAN, Irvine, California 92612, NDC 0023-0313-04, UPC 3 00230 31304 9.
- Lots / codes affected
- Lot #: 86430, Exp 09/17; 87806, Exp 02/18; 88147, Exp 03/18
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.